Search Results
Results found for "custom ligand development"
- Addex Raises $10 Million In Equity Financing
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- California gold rush for Sosei Heptares
The vision is to develop novel muscarinic receptor agonists for schizophrenia and other neuropsychiatric
- Misread the Curve, Misjudge the Drug: Rethinking Antagonism in GPCR Pharmacology
pharmacologists misinterpret how an antagonist interacts with its receptor, the consequences ripple across assay development
- Lysine 101 in the CRAC Motif in Transmembrane Helix 2 Confers Cholesterol-Induced Thermal...
in structural biological advancements of GPCRs and design of thermally stabilized receptors for drug development
- Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
library for its industry-leading biology platform to identify potential GPCR targets and advance the development
- Gαs and Gαq/11 protein coupling bias of two AVPR2 mutants (R68W and V162A) that cause nephrogenic di
conformation of the receptor and consequently activated signaling pathways, and also may shed light on the development
- Addex raises $4.2 million in equity financing
, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development
- Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage ...
translational medicine capabilities • ‘Venture-like’ capital allocation approach to focus pipeline development
- Effect Delta-9-tetrahydrocannabinol and cannabidiol on milk proteins and lipid levels in HC11 cells
impact of cannabis or its components, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), on MG development
- GRK2 in cardiovascular disease and its potential as a therapeutic target
Thus, identifying novel molecular targets for developing HF therapeutics remains a key research focus
- Newly launched antibody libraries put hard-to-drug targets within reach
Antibody developers are increasingly utilising antibody libraries to derive high-quality, drug-like biologics
- Increased Anxiety-like Behaviors in Adgra1-/- Male But Not Female Mice are Attributable to...
amygdalae of male mice, implicating a potential, therapeutic application in novel anti-anxiety drug development
- Enhanced membrane binding of oncogenic G protein αqQ209L confers resistance to inhibitor YM-254890
if this loss of PM localization could contribute to the mechanism of inhibition of αqQ209L by YM, we developed
- TeachOpenCADD - A teaching platform for computer-aided drug design
TeachOpenCADD is a teaching platform developed by students for students, which provides teaching material
- GPR125 (ADGRA3) is an autocleavable adhesion GPCR that traffics with Dlg1 to the basolateral...
These receptors are expressed widely and involved in various functions including development, angiogenesis
- Trevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...
royalty on net sales in China CHESTERBROOK, Pa., Jan. 27, 2022 A biopharmaceutical company focused on the development
- Applications of Cryo-EM in small molecule and biologics drug design
opportunities afforded by emerging technological advances in cryo-EM, and the prospects for future development
- Engineered synaptic tools reveal localized cAMP signaling in synapse assembly
SynTAMs" for synaptic targeting molecules, that enable localized perturbations of cAMP signaling in developing
- 📰 GPCR Weekly News
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- A Model for the Signal Initiation Complex Between Arrestin-3 and the Src Family Kinase Fgr
this interaction, we determined the crystal structure of the Fgr SH3 domain at 1.9 Å resolution and developed
- GPCRS: AN ODYSSEY FROM STRUCTURE, SIGNALING AND REGULATION TO THERAPEUTICS
study of GPCR action in multiple systems, but also offers exciting opportunities in the translational development
- Unveiling GPCR Priming: The Hidden Synergy in Cellular Signalling
This has significant implications for drug development, as targeting these non-cognate interactions could
- Structural dynamics of Smoothened (SMO) in ciliary membrane and its interaction with membrane lipids
protein) plays a crucial role in the Hedgehog (HH) signaling pathway, which is involved in embryonic development
- Bursicon receptor gene HLGR2 as a potential RNA interference target for control of the fall ...
Conclusion: HLGR2 is essential for the growth and development and wing expansion and maturation in H.
- Involvement of various chemokine/chemokine receptor axes in trafficking and oriented locomotion ...
Thus, the development of novel and safe medications needs to be considered for the disease management
- Why Biotech Fundraising Fails Due to Intellectual Property Gaps
Intellectual property is increasingly evaluated together with development plans and commercial intent
- 📰 GPCR Weekly News, June 19 to 25, 2023
Stay up-to-date as the program develops by subscribing to our monthly Dr. GPCR Newsletter.
- 📰 GPCR Weekly News, May 22 to 28, 2023
Progressive Technologies and Approaches Revealing Novel GPCR Biology and Drug Development Potential.
- Nanobodies: New Dimensions in GPCR Signaling Research
All the above lightly represent the potential applications of Nbs to facilitate the development of more
- 📰 GPCR Weekly News, May 6 to 12, 2024
Quarter 2024 Crinetics Pharmaceuticals To Present Advancements From Atumelnant (Crn04894) And Paltusotine Development



